-+ 0.00%
-+ 0.00%
-+ 0.00%

CATALYST PHARMACEUTICALS INC - BENCH TRIAL CONCERNS VALIDITY OF FIRDAPSE PATENTS EXPIRING IN 2032, 2034, 2037 - SEC FILING

Reuters·03/18/2026 21:22:18

Please log in to view news